患有大动脉疾病和高血压的患者血中阿尔多素度较高:一项追溯观察性研究
Yuting Pu1,2, Guifang Yang1,2, Xiaogao Pan1,2
1Department of Emergency Medicine, The Second Xiangya Hospital, Central South University, 139 Renmin Road, Changsha, 410011, Hunan, China.
European journal of medical research
|November 26, 2023
概括
患有大动脉疾病的高血压患者表现出更高的血阿尔多素度 (PAC). 这项研究探讨了高血压个体中PAC和大动脉疾病之间的联系,表明大动脉疾病患者的PAC升高.
科学领域:
- 心血管医学 心血管医学
- 内分泌学 在内分泌学.
- 高血压研究 高血压研究
背景情况:
- 大动脉疾病代表着重要的血管健康风险.
- 血中阿尔多素度 (PAC) 和大动脉疾病之间的联系尚未得到充分研究.
- 这项研究研究了高血压患者有或没有大动脉疾病的PAC差异.
研究的目的:
- 为了确定血阿尔多素度 (PAC) 在高血压患者之间是否有差异,有或没有大动脉疾病.
- 在高血压队列中探索PAC和大动脉疾病之间的关联.
主要方法:
- 分析了926名高血压患者的电子病历,包括PAC测量.
- 包括/排除标准定义案例和对照组.
- 用多变量逻辑回归和倾向得分匹配来分析PAC差异和对混因子的控制.
主要成果:
- 分析了394名参与者 (66名有大动脉疾病).
- 患有大动脉疾病的高血压患者显示PAC升高的可能性更高 (OR=1.138).
- 在控制混因素和通过倾向性得分匹配后,这种关联仍然存在.
结论:
- 患有大动脉疾病的初级高血压患者表现出高血阿尔多素度 (PAC).
- 需要进一步的研究来确定PAC与大动脉疾病之间的因果关系.
相关概念视频
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
654
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
654
Antihypertensive Drugs: Angiotensin II Receptor Blockers
748
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
748
Hormonal Regulation
33.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.2K
Regulation of Sodium and Potassium
554
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
554
Antihypertensive Drugs: Direct Renin Inhibitors
637
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
637


